Y-Mabs Therapeutics Inc

NASDAQ:YMAB   3:59:58 PM EDT
40.13
+2.27 (+6.00%)
Products

Y-Mabs Announces FDA Clearance Of Ind For Its Lutetium-177 Labeled Omburtamab Antibody

Published: 10/14/2020 13:27 GMT
Y-mAbs Therapeutics, Inc. (YMAB) - Y-mabs Announces FDA Clearance of Ind for Its Lutetium-177 Labeled Omburtamab Antibody.
Y-mabs - Expect International Multicenter Phase 1/2 Clinical Trial to Be Initiated for Screening of Pediatric Patients With Medulloblastoma During Q4.